Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shanshan Zhou

Showing results (201-210 of 368) with videos related to

Pageof 37
Sort By:
Cell Biology International|May 10, 2018
Angiotensin II enhances the acetylation and release of HMGB1 in RAW264.7 macrophageShanshan Zhou, Hongxiang Lu, Rong Chen, et al.
Toxicology Letters|February 7, 2018
Protection by dimethyl fumarate against diabetic cardiomyopathy in type 1 diabetic mice likely via activation of nuclear factor erythroid-2 related factor 2Xinyue Hu, Mohanraj Rajesh, Jian Zhang, et al.
Cell Stress & Chaperones|July 22, 2015
Donepezil attenuates high glucose-accelerated senescence in human umbilical vein endothelial cells through SIRT1 activationTao Zhang, Feng Tian, Jing Wang, et al.
Cardiology in Review|October 5, 2019
Very Late Stent Thrombosis in Drug-Eluting Stents New Observations and Clinical ImplicationsXiang Wang, Xinxin Chen, Wanqing Sun, et al.
Electrophoresis|April 26, 2008
Simultaneous separation of eight beta-adrenergic drugs using titanium dioxide nanoparticles as additive in capillary electrophoresisShanshan Zhou, Yanqing Wang, Thomas De Beer, et al.
Reviews in Endocrine & Metabolic Disorders|December 26, 2014
The role of the Nrf2/Keap1 pathway in obesity and metabolic syndromeZhiguo Zhang, Shanshan Zhou, Xin Jiang, et al.
International Immunopharmacology|February 8, 2018
HMGB1 silencing in macrophages prevented their functional skewing and ameliorated EAM development: Nuclear HMGB1 may be a checkpoint molecule of macrophage reprogrammingYuanyuan Jiang, Rong Chen, Xiaoyi Shao, et al.
BMJ Open|December 7, 2019
Impact of metoprolol standard dosing pathway in Chinese patients with acute coronary syndrome: protocol for a multicentre prospective studyDandan Li, Wei Dong, Yuqi Liu, et al.
Peerj|May 16, 2019
Risk factors for repeat percutaneous coronary intervention in young patients (≤45 years of age) with acute coronary syndromeTianwen Han, Qun Wang, Huanwan Yang, et al.
Medicine|September 9, 2025
In vivo quantitative assessment of atherosclerotic plaque: A validation study on the optical coherence tomography-derived index of plaque attenuationXingxuan Cai, Yihui Cao, Quanmao Lu, et al.
Pageof 37

Showing results (201-210 of 368) with videos related to

Sort By:
Pageof 37
Cell Biology International|May 10, 2018
Angiotensin II enhances the acetylation and release of HMGB1 in RAW264.7 macrophageShanshan Zhou, Hongxiang Lu, Rong Chen, et al.
Toxicology Letters|February 7, 2018
Protection by dimethyl fumarate against diabetic cardiomyopathy in type 1 diabetic mice likely via activation of nuclear factor erythroid-2 related factor 2Xinyue Hu, Mohanraj Rajesh, Jian Zhang, et al.
Cell Stress & Chaperones|July 22, 2015
Donepezil attenuates high glucose-accelerated senescence in human umbilical vein endothelial cells through SIRT1 activationTao Zhang, Feng Tian, Jing Wang, et al.
Cardiology in Review|October 5, 2019
Very Late Stent Thrombosis in Drug-Eluting Stents New Observations and Clinical ImplicationsXiang Wang, Xinxin Chen, Wanqing Sun, et al.
Electrophoresis|April 26, 2008
Simultaneous separation of eight beta-adrenergic drugs using titanium dioxide nanoparticles as additive in capillary electrophoresisShanshan Zhou, Yanqing Wang, Thomas De Beer, et al.
Reviews in Endocrine & Metabolic Disorders|December 26, 2014
The role of the Nrf2/Keap1 pathway in obesity and metabolic syndromeZhiguo Zhang, Shanshan Zhou, Xin Jiang, et al.
International Immunopharmacology|February 8, 2018
HMGB1 silencing in macrophages prevented their functional skewing and ameliorated EAM development: Nuclear HMGB1 may be a checkpoint molecule of macrophage reprogrammingYuanyuan Jiang, Rong Chen, Xiaoyi Shao, et al.
BMJ Open|December 7, 2019
Impact of metoprolol standard dosing pathway in Chinese patients with acute coronary syndrome: protocol for a multicentre prospective studyDandan Li, Wei Dong, Yuqi Liu, et al.
Peerj|May 16, 2019
Risk factors for repeat percutaneous coronary intervention in young patients (≤45 years of age) with acute coronary syndromeTianwen Han, Qun Wang, Huanwan Yang, et al.
Medicine|September 9, 2025
In vivo quantitative assessment of atherosclerotic plaque: A validation study on the optical coherence tomography-derived index of plaque attenuationXingxuan Cai, Yihui Cao, Quanmao Lu, et al.
Pageof 37